Voltage-gated K + (Kv) channels play critical roles not only in regulating synaptic transmission and intrinsic excitability of neurons, but also in controlling the function and proliferation of other cells in the central nervous system (CNS). The non-specific Kv channel blocker, 4-AminoPyridine (4-AP) (Dalfampridine, Ampyra®), is currently used to treat multiple sclerosis (MS), an inflammatory demyelinating disease. However, little is known how various types of Kv channels are altered in any inflammatory demyelinating diseases. By using established animal models for MS, experimental autoimmune encephalomyelitis (EAE), we report that expression and distribution patterns of Kv channels are altered in the CNS correlating with EAE severity. The juxtaparanodal (JXP) targeting of Kv1.2/Kvβ2 along myelinated axons is disrupted within demyelinated lesions in the white matter of spinal cord in EAE. Moreover, somatodendritic Kv2.1 channels in the motor neurons of lower spinal cord significantly decrease correlating with EAE severity. Interestingly, Kv1.4 expression surrounding lesions is markedly up-regulated in the initial acute phase of both EAE models. Its expression in glial fibrillary acidic protein (GFAP)-positive astrocytes further increases in the remitting phase of remitting-relapsing EAE (rrEAE), but decreases in late chronic EAE (chEAE) and the relapse of rrEAE, suggesting that Kv1.4-positive astrocytes may be neuroprotective. Taken together, our studies reveal myelin-dependent and -independent alterations of Kv channels in the progression of EAE and lay a solid foundation for future study in search of a better treatment for MS.
Introduction
MS is an inflammatory demyelinating disease of the CNS that is thought to have an autoimmune pathogenesis. Myelin damage can impair action potential (AP) propagation along axons, leading to various neurophysiological abnormalities. Ion channels are implicated in neuronal dysfunction in MS, such as axon conduction failure and axonal degeneration (Waxman, 1982; Kornek et al., 2001; Waxman, 2002; Judge and Bever, 2006; Waxman, 2006) . In particular, axonal Kv channels, to hyperpolarize membrane potentials toward the resting level, play critical roles in regulating the initiation, waveform, frequency and uni-directional propagation of APs (Hodgkin and Huxley, 1952; Hille, 2001; Debanne, 2004; Gu and Barry, 2011) . Blocking axonal Kv channel activity can enhance axon conduction, which may underlie the beneficial effects of 4-AP in symptomatic treatment of MS, such as improving balance, vision, walking speed and leg strength, etc. (Hayes, 2004; Judge and Bever, 2006; Goodman et al., 2009; Espejo and Montalban, 2012; Goodman et al., 2010) . However, the treatment does not cure MS and has side effects. This appears consistent with complex expression and targeting patterns of Kv channels.
Kv1 channels are a major subfamily of axonal Kv channels present in both the CNS and peripheral nervous system (PNS). Kv1.1, Kv1.2, and Kvβ2 are clustered in the JXP regions under the myelin sheath along myelinated axons in brain and spinal cord (Wang et al., 1993; Rhodes et al., 1995; Wang et al., 1995; Rhodes et al., 1997; Rasband et al., 1999; Vabnick et al., 1999; Rasband and Shrager, 2000; Trimmer and Rhodes, 2004) . These channels constrain repetitive firing of APs in normal myelinated axons (Zhou et al., 1998) , and reduce axonal excitability in pre-myelinated axons during early development and demyelinated axons in diseases (Rasband et al., 1998; Sinha et al., 2006) . Furthermore, they are also present in unmyelinated axons, such as cerebellar basket cell terminals (Wang et al., 1994; Rhodes et al., 1997) . Kv1.4, carrying transient currents, resides in unmyelinated hippocampal mossy fibers and in small diameter and unmyelinated axons of dorsal root ganglion neurons, but not in the JXP regions of large diameter and myelinated axons (Sheng et al., Neurobiology of Disease 47 (2012) 280-293 
